Description

Enoxaparin Solution for Injections 10000 anti-Cha IU/ml. 0.6 ml Syringe

Ingredients

Enoxaparin solution for injections contains 10000 anti-Cha IU/ml as the active ingredient. Other ingredients may include stabilizers and buffers to maintain the stability and efficacy of the solution.

Dosage

The recommended dosage of Enoxaparin solution for injections is determined by a healthcare professional based on the patient’s condition, weight, and other factors. It is typically administered subcutaneously once or twice daily.

Indications

Enoxaparin is indicated for the prevention and treatment of blood clots in conditions such as deep vein thrombosis, pulmonary embolism, and during certain surgical procedures.

Contraindications

Patients with a history of heparin-induced thrombocytopenia, active major bleeding, or hypersensitivity to enoxaparin should not use this medication. It is important to consult a healthcare provider before starting treatment.

Directions

Administer the injection subcutaneously as directed by a healthcare professional. Avoid injecting into muscle or veins. Rotate injection sites to prevent irritation.

Scientific Evidence

Enoxaparin has been extensively studied in various clinical trials and has shown efficacy in preventing and treating blood clots. Research published in the New England Journal of Medicine demonstrated the effectiveness of enoxaparin in reducing the risk of venous thromboembolism in patients undergoing orthopedic surgery.

Additional Information

It is important to monitor for signs of bleeding while using enoxaparin. In case of unusual bleeding or bruising, contact a healthcare provider immediately. Store the syringe at the recommended temperature to maintain its stability.

Pharmacological Effects: Enoxaparin is a low molecular weight heparin that works by inhibiting the activity of certain clotting factors in the blood, thereby preventing the formation of blood clots. It has a more predictable anticoagulant response compared to unfractionated heparin.

Comparative Effectiveness: Studies have shown that enoxaparin is as effective as unfractionated heparin in preventing deep vein thrombosis and pulmonary embolism. However, enoxaparin has the advantage of a lower risk of heparin-induced thrombocytopenia.